自身免疫性脑炎患者中18F-DPA714 PET/MRI与18F-FDG PET/CT的头对头比较:一项横断面研究
结果显示18F-FDG PET和18F-DPA714 PET的阳性率均高于MRI(分别为81%对44%,P=0.006;76%对44%,P=0.008),且18F-DPA714的摄取强度和范围与mRS评分及CASE评分存在统计学显著关联,而18F-FDG无此关联。作者认为18F-DPA714 PET与疾病严重程度的相关性优于18F-FDG PET,可作为18F-FDG PET和MRI的补充工具。
要点
- 18F-FDG PET和18F-DPA714 PET阳性率均高于MRI(81%对44%,P=0.006;76%对44%,P=0.008)。
- 18F-DPA714的摄取强度和范围与mRS评分及CASE评分呈统计学显著关联,18F-FDG无此关联。
- 作者认为18F-DPA714 PET与疾病严重程度的相关性优于18F-FDG PET,可作为后者的补充工具。
核心结论
- 18F-DPA714 PET与自身免疫性脑炎疾病严重程度的相关性优于18F-FDG PET,可作为18F-FDG PET和MRI的补充工具。
研究设计与样本
- 横断面研究,纳入23例抗体阳性和2例可能抗体阴性的自身免疫性脑炎患者,以及10例健康对照。
- 所有患者在一周内序贯完成18F-DPA714 PET/MRI和18F-FDG PET/CT检查,基线检查后随访6至12个月以评估临床症状变化。
主要发现
- 18F-FDG PET阳性率为81%,MRI为44%,两者比较P=0.006;18F-DPA714 PET阳性率为76%,MRI为44%,两者比较P=0.008。
- 18F-DPA714的摄取强度和范围与mRS评分及CASE评分存在统计学显著关联,18F-FDG无此关联。
- 合并癫痫的患者较无癫痫患者在全皮层18F-DPA714摄取(P=0.0014)、全皮层18F-FDG摄取(P=0.0051)及颞叶18F-FDG摄取(P=0.0216)均显著更高。
- 长期认知障碍患者较无长期认知障碍患者全皮层18F-DPA714 SUVR更高(P<0.001)、全皮层18F-FDG SUVR更低(P<0.001)。
关键数值与推荐
- 18F-DPA714 PET阳性定义为相应脑区Z值高于健康对照2.0以上。
- 18F-FDG PET阳性定义为与正常人群数据库比较后Z值高于2.0或低于-2.0。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIM: The positive detection rate of MRI in autoimmune encephalitis (AIE) patients is low, often failing to make a rapid and accurate localization diagnosis. Both 18F-DPA714 and 18F-FDG PET imaging techniques have shown their advantages in the diagnosis of AIE. Therefore, the aim of this study was to conduct a head-to-head comparison of the diagnostic value between 18F-DPA714 and 18F-FDG PET in patients with AIE. METHODS: This cross-sectional study included 23 antibody-positive and 2 possible antibody-negative AIE patients, along with 10 healthy controls. All patients underwent sequential 18F-DPA714 PET/MRI and 18F-FDG PET/CT examinations within one week. A follow-up of 6 to 12 months after the baseline examinations was performed to assess the change of patients' clinical symptoms. Positive findings for 18F-DPA714 PET were defined as Z-score above 2.0 in the corresponding brain regions of healthy controls. Positive results for 18F-FDG PET were indicated by the Z-score above 2.0 or below -2.0 obtained after comparison with the normal population database. RESULTS: Both 18F-FDG PET and 18F-DPA714 PET showed higher positivity rates than MRI (81% vs 44%, P = 0.006 and 76% vs 44%, P = 0.008, respectively). A statistically significant association was found between the uptake intensity and extent of 18F-DPA714 but not 18F-FDG with the mRS scores and the CASE scores. Patients with epilepsy showed a significantly higher uptake in the whole-cortex of both 18F-DPA714 (P = 0.0014) and 18F-FDG (P = 0.0051) and in the temporal lobe of 18F-FDG (P = 0.0216) compared to those patients without. Higher 18F-DPA714 SUVR (P < 0.001) and lower 18F-FDG SUVR (P < 0.001) in the whole-cortex of patients with long-term cognitive impairment than those patients without were observed. CONCLUSION: 18F-DPA714 PET showed its better correlation with disease severity of AIE than 18F-FDG PET, serving as a supplementary tool to 18F-FDG PET and MRI.
引用
- Meng H, Chen X, He L, et al. Comparison of 18F-DPA714 PET/MRI and 18F-FDG PET/CT in patients with autoimmune encephalitis: a cross-sectional study. Eur J Nucl Med Mol Imaging. 2025. PMID: 40317304. doi:10.1007/s00259-025-07305-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。